Cargando…

Epigenetic Alterations in Bladder Cancer and Their Potential Clinical Implications

Urothelial carcinoma (UC), the most common type of bladder cancer, is one of the most expensive malignancies to treat due to its high rate of recurrence. The characterization of the genetic alterations associated with UC has revealed the presence of two mutually exclusive molecular pathways along wh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Han, Wolff, Erika M., Liang, Gangning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3397159/ https://www.ncbi.nlm.nih.gov/pubmed/22829811 http://dx.doi.org/10.1155/2012/546917

Ejemplares similares

Genetic and Epigenetic Alterations in Bladder Cancer
por: Li, Hong-Tao, et al.
Publicado: (2016)

Alterations of Epigenetic Regulators in Pancreatic Cancer and Their Clinical Implications
por: Silverman, Brittany R., et al.
Publicado: (2016)

Hypomethylation of a LINE-1 Promoter Activates an Alternate Transcript of the MET Oncogene in Bladders with Cancer
por: Wolff, Erika M., et al.
Publicado: (2010)

Alteration of Epigenetic Modifiers in Pancreatic Cancer and Its Clinical Implication
por: Hung, Yu-Hsuan, et al.
Publicado: (2019)

Clinical evaluation of Bladder CARE, a new epigenetic test for bladder cancer detection in urine samples
por: Piatti, Paolo, et al.
Publicado: (2021)

Synergistic Re-Activation of Epigenetically Silenced Genes by Combinatorial Inhibition of DNMTs and LSD1 in Cancer Cells
por: Han, Han, et al.
Publicado: (2013)

Rewiring of cisplatin-resistant bladder cancer cells through epigenetic regulation of genes involved in amino acid metabolism
por: Yeon, Austin, et al.
Publicado: (2018)

HER3 Alterations in Cancer and Potential Clinical Implications
por: Kilroy, Mary Kate, et al.
Publicado: (2022)

Epigenetic Markers for Bladder Cancer in Urine
por: Kim, Wun-Jae, et al.
Publicado: (2007)

Epigenetic and Immunological Features of Bladder Cancer
por: Gilyazova, Irina, et al.
Publicado: (2023)

The epigenetic effects of butyrate: potential therapeutic implications for clinical practice
por: Berni Canani, Roberto, et al.
Publicado: (2012)

The Placenta as a Target of Epigenetic Alterations in Women with Gestational Diabetes Mellitus and Potential Implications for the Offspring
por: Lizárraga, Dennise, et al.
Publicado: (2021)

Epigenetic Alterations of Heat Shock Proteins (HSPs) in Cancer
por: Ban, Hyun Seung, et al.
Publicado: (2019)

New Insights into the Implication of Epigenetic Alterations in the EMT of Triple Negative Breast Cancer
por: Khaled, Noura, et al.
Publicado: (2019)

Prostate cancer epigenetics and its clinical implications
por: Yegnasubramanian, Srinivasan
Publicado: (2016)

Epigenetics in prostate cancer: clinical implications
por: Conteduca, Vincenza, et al.
Publicado: (2021)

Combined genetic and epigenetic alterations of the TERT promoter affect clinical and biological behavior of bladder cancer
por: Leão, Ricardo, et al.
Publicado: (2018)

Epigenetic Alterations in Parathyroid Cancers
por: Verdelli, Chiara, et al.
Publicado: (2017)

Clinical and pathological implications of miRNA in bladder cancer
por: Braicu, Cornelia, et al.
Publicado: (2015)

Clinical implications of underactive bladder
por: Ko, Kwang Jin, et al.
Publicado: (2017)

Epigenetic regulation of prostate cancer: the theories and the clinical implications
por: Liao, Yiji, et al.
Publicado: (2019)

New Approaches to Targeting Epigenetic Regulation in Bladder Cancer
por: Thompson, Daryl, et al.
Publicado: (2023)

Autotaxin in Breast Cancer: Role, Epigenetic Regulation and Clinical Implications
por: Drosouni, Andrianna, et al.
Publicado: (2022)

Epigenetic Alterations in Immune Cells of Systemic Lupus Erythematosus and Therapeutic Implications
por: Adams, David E., et al.
Publicado: (2022)

Epigenetically regulated gene expression profiles recognized three molecular classifications with prognostic and therapeutic implications in bladder cancer
por: Xu, Hui, et al.
Publicado: (2023)

Genetic alterations and epigenetic alterations of cancer-associated fibroblasts
por: Du, Heng, et al.
Publicado: (2017)

Implications of Genetic and Epigenetic Alterations of CDKN2A (p16(INK4a)) in Cancer
por: Zhao, Ran, et al.
Publicado: (2016)

Gastric cancer and related epigenetic alterations
por: Patel, Trupti N, et al.
Publicado: (2017)

Exploiting Epigenetic Alterations in Prostate Cancer
por: Baumgart, Simon J., et al.
Publicado: (2017)

Epigenetic Alterations in Pancreatic Cancer Metastasis
por: Wang, Sarah S., et al.
Publicado: (2021)

Epigenetic Mechanisms Influencing Epithelial to Mesenchymal Transition in Bladder Cancer
por: Monteiro-Reis, Sara, et al.
Publicado: (2019)

Epigenetic Drugs and Their Immune Modulating Potential in Cancers
por: Liang, Yingying, et al.
Publicado: (2022)

Variant histology in bladder cancer: diagnostic and clinical implications
por: Black, Anna J., et al.
Publicado: (2020)

Metabolic Signaling to Epigenetic Alterations in Cancer
por: Kim, Jung-Ae, et al.
Publicado: (2018)

Epigenetic alterations and genetic variations of angiotensin-converting enzyme 2 (ACE2) as a functional receptor for SARS-CoV-2: potential clinical implications
por: Kianmehr, Anvarsadat, et al.
Publicado: (2021)

Epigenetic Alterations in Inflammatory Bowel Disease and Cancer
por: Yi, Joo Mi, et al.
Publicado: (2015)

Epigenetic Alterations in Human Papillomavirus-Associated Cancers
por: Soto, David, et al.
Publicado: (2017)

Evolutional and clinical implications of the epigenetic regulation of protein glycosylation
por: Horvat, Tomislav, et al.
Publicado: (2011)

Clinical Potential of Fruit in Bladder Cancer Prevention and Treatment
por: Wigner, Paulina, et al.
Publicado: (2022)

Prostate Cancer: Epigenetic Alterations, Risk Factors, and Therapy
por: Kgatle, Mankgopo M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9461vcjr51r3ib0si9l2gukack